After multiple doses, mean IGF-1 levels remained above baseline for up to 28 days, with no serious adverse reactions reported establishing the GHRH-analogue backbone as capable of sustained, clinically meaningful GH and IGF-1 axis elevation
Like, there's nothing wrong with money
Researchers interested in this protocol design can review the CJC-1295 No DAC + Ipamorelin Blend, which pairs a GHRH-family analog with ipamorelin for study of sustained growth hormone release and body composition endpoints
Although increases in liver function tests may be an artefact caused by changes to the diet, exercise and environment of volunteers in clinical studies, the findings must be carefully consid-ered before ruling out adaptive changes or toxicity
Any discussion of timing, signaling patterns, or pathway selectivity is provided only for research context and must not be interpreted as a human-use claim